Kyowa Kirin Co., Ltd. (OTCMKTS:KYKOF) Short Interest Up 36.1% in February

Kyowa Kirin Co., Ltd. (OTCMKTS:KYKOF) was the target of a large increase in short interest in the month of February. As of February 15th, there was short interest totalling 495,100 shares, an increase of 36.1% from the January 31st total of 363,800 shares. Based on an average trading volume of 200 shares, the short-interest ratio is presently 2,475.5 days.

Kyowa Kirin Stock Performance

Shares of KYKOF stock remained flat at $12.32 during mid-day trading on Wednesday. Kyowa Kirin has a twelve month low of $12.32 and a twelve month high of $22.21. The business’s 50-day moving average price is $14.48 and its 200-day moving average price is $17.12.

Kyowa Kirin Company Profile

Kyowa Kirin Co, Ltd. engages in the research, development, manufacturing, marketing, and import/export of pharmaceuticals for oncology, nephrology, central nervous system, and immunology therapeutic areas in Japan, the United States, rest of the Americas, Europe, Asia, and internationally. Its products include ALLELOCK, an antihistamine agent for patients with various types of allergies; CONIEL, a calcium channel blocker for hypertension and angina pectoris; Crysvita, a recombinant human monoclonal IgG1 antibody against the phosphaturic hormone fibroblast growth factor 23; ESPO, a glycoprotein and human erythropoietin; NESP, an erythropoiesis stimulating agent; and GRAN, a human colony-stimulating factor.